Literature DB >> 10207167

Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome.

A Jain1, T P Atkinson, P E Lipsky, J E Slater, D L Nelson, W Strober.   

Abstract

X-linked hyper-IgM syndrome (XHIM) results from mutations in the gene encoding for CD40 ligand (CD154). Patients with the syndrome suffer from infections with opportunistic pathogens such as Cryptosporidium and Pneumocystis carinii. In this study, we demonstrate that activated T cells from patients with XHIM produce markedly reduced levels of IFN-gamma, fail to induce antigen-presenting cells to synthesize IL-12, and induce greatly reduced levels of TNF-alpha. In addition, we show that the patients' circulating T lymphocytes of both the CD4(+) and CD8(+) subsets contain a markedly reduced antigen-primed population, as determined by CD45RO expression. Finally, we demonstrate that the defects in antigen priming are likely due to the lack of CD154 expression and insufficient costimulation of T cells by CD80/CD86 interactions. Taken together, this study offers a basis for the increased susceptibility of patients with XHIM to certain opportunistic infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207167      PMCID: PMC408278          DOI: 10.1172/JCI5891

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  CD45 isoform expression during T cell development in the thymus.

Authors:  Y Fujii; M Okumura; K Inada; K Nakahara; H Matsuda
Journal:  Eur J Immunol       Date:  1992-07       Impact factor: 5.532

2.  Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.

Authors:  H Gascan; J F Gauchat; G Aversa; P Van Vlasselaer; J E de Vries
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

3.  Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

Authors:  H M Serra; J F Krowka; J A Ledbetter; L M Pilarski
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

4.  Hyper immunoglobulin M immunodeficiency. (Dysgammaglobulinemia). Presence of immunoglobulin M-secreting plasmacytoid cells in peripheral blood and failure of immunoglobulin M-immunoglobulin G switch in B-cell differentiation.

Authors:  R S Geha; N Hyslop; S Alami; F Farah; E E Schneeberger; F S Rosen
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

Review 5.  Immunodeficiency with hyper-IgM (HIM).

Authors:  L D Notarangelo; M Duse; A G Ugazio
Journal:  Immunodefic Rev       Date:  1992

6.  A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease.

Authors: 
Journal:  N Engl J Med       Date:  1991-02-21       Impact factor: 91.245

7.  Age-related changes in human blood lymphocyte subpopulations.

Authors:  F M Erkeller-Yuksel; V Deneys; B Yuksel; I Hannet; F Hulstaert; C Hamilton; H Mackinnon; L T Stokes; V Munhyeshuli; F Vanlangendonck
Journal:  J Pediatr       Date:  1992-02       Impact factor: 4.406

8.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.

Authors:  A Aruffo; M Farrington; D Hollenbaugh; X Li; A Milatovich; S Nonoyama; J Bajorath; L S Grosmaire; R Stenkamp; M Neubauer
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

9.  Definition of the thymic generative lineage by selective expression of high molecular weight isoforms of CD45 (T200).

Authors:  L M Pilarski; R Gillitzer; H Zola; K Shortman; R Scollay
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

10.  Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

Authors:  T Defrance; B Vanbervliet; F Brière; I Durand; F Rousset; J Banchereau
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more
  32 in total

1.  Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets.

Authors:  H Uronen; R E Callard
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and race and comparison with other published studies.

Authors:  Wee J Chng; Guat B Tan; Ponnudurai Kuperan
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

Review 3.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

Review 4.  Disseminated Cutaneous Warts in X-Linked Hyper IgM Syndrome.

Authors:  Hsi-En Ho; Minji Byun; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2018-05-05       Impact factor: 8.317

5.  Impaired dendritic-cell function in ectodermal dysplasia with immune deficiency is linked to defective NEMO ubiquitination.

Authors:  Stephane T Temmerman; Chi A Ma; Louis Borges; Marek Kubin; Shuying Liu; Jonathan M J Derry; Ashish Jain
Journal:  Blood       Date:  2006-06-22       Impact factor: 22.113

6.  Immunodeficiencies due to defects of class-switch recombination.

Authors:  Luigi D Notarangelo; Gaetana Lanzi; Paola Toniati; Silvia Giliani
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 7.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

8.  First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.

Authors:  Otavio Cabral-Marques; Stefanie Klaver; Lena F Schimke; Évelyn H Ascendino; Taj Ali Khan; Paulo Vítor Soeiro Pereira; Angela Falcai; Alexander Vargas-Hernández; Leopoldo Santos-Argumedo; Liliana Bezrodnik; Ileana Moreira; Gisela Seminario; Daniela Di Giovanni; Andrea Gómez Raccio; Oscar Porras; Cristina Worm Weber; Janaíra Fernandes Ferreira; Fabiola Scancetti Tavares; Elisa de Carvalho; Claudia França Cavalcante Valente; Gisele Kuntze; Miguel Galicchio; Alejandra King; Nelson Augusto Rosário-Filho; Milena Baptistella Grota; Maria Marluce dos Santos Vilela; Regina Sumiko Watanabe Di Gesu; Simone Lima; Leiva de Souza Moura; Eduardo Talesnik; Eli Mansour; Pérsio Roxo-Junior; Juan Carlos Aldave; Ekaterine Goudouris; Fernanda Pinto-Mariz; Laura Berrón-Ruiz; Tamara Staines-Boone; Wilmer O Córdova Calderón; María del Carmen Zarate-Hernández; Anete S Grumach; Ricardo Sorensen; Anne Durandy; Troy R Torgerson; Beatriz Tavares Costa Carvalho; Francisco Espinosa-Rosales; Hans D Ochs; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2014-01-09       Impact factor: 8.317

9.  A primary immunodeficiency disorder associated with absence of lymphoid germinal centers.

Authors:  Eli M Eisenstein; Memet Aker; Gianfranco Savoldi; Ronald Jaffe; Diana Prus
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

10.  Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.

Authors:  M Teresa de la Morena; David Leonard; Troy R Torgerson; Otavio Cabral-Marques; Mary Slatter; Asghar Aghamohammadi; Sharat Chandra; Luis Murguia-Favela; Francisco A Bonilla; Maria Kanariou; Rongras Damrongwatanasuk; Caroline Y Kuo; Christopher C Dvorak; Isabelle Meyts; Karin Chen; Lisa Kobrynski; Neena Kapoor; Darko Richter; Daniela DiGiovanni; Fatima Dhalla; Evangelia Farmaki; Carsten Speckmann; Teresa Español; Anna Shcherbina; Imelda Celine Hanson; Jiri Litzman; John M Routes; Melanie Wong; Ramsay Fuleihan; Suranjith L Seneviratne; Trudy N Small; Ales Janda; Liliana Bezrodnik; Reinhard Seger; Andrea Gomez Raccio; J David M Edgar; Janet Chou; Jordan K Abbott; Joris van Montfrans; Luis Ignacio González-Granado; Nancy Bunin; Necil Kutukculer; Paul Gray; Gisela Seminario; Srdjan Pasic; Victor Aquino; Christian Wysocki; Hassan Abolhassani; Morna Dorsey; Charlotte Cunningham-Rundles; Alan P Knutsen; John Sleasman; Beatriz Tavares Costa Carvalho; Antonio Condino-Neto; Eyal Grunebaum; Helen Chapel; Hans D Ochs; Alexandra Filipovich; Mort Cowan; Andrew Gennery; Andrew Cant; Luigi D Notarangelo; Chaim M Roifman
Journal:  J Allergy Clin Immunol       Date:  2016-09-30       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.